아스테라시스

450950KOSDAQ의료용 기기 제조업

56.5 / 100

Reference Date: 2026-04-13

Financial Score25.0 / 40

News Sentiment12.5 / 25

Momentum9.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but PBR raises overvaluation concerns. Declined 8.0% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Astersis is a company specializing in the production and sale of medical devices for aesthetic treatments, focusing on high-intensity focused ultrasound (HIFU) and radiofrequency (RF) technologies. Its flagship product, Liftera, stands out for reduced patient discomfort and enhanced efficacy, driving market differentiation. The company is expanding globally through new product development and international certifications, including FDA approval targeting 2025.

Number of Employees

88people

Average Salary

106.7M KRW

Score Calculation Basis

Detailed Financial Score

PER

43.08Industry Average 26.521.5Point

1.6x industry avg (risky)

PBR

8.67Industry Average 1.700.0Point

5.1x industry avg (risky)

ROE

27.74Industry Average 8.007.0Point

3.5x industry avg (excellent)

Debt Ratio

0.39Industry Average 10.958.0Point

Half of industry avg (excellent)

Trend 2024~20258.5 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲31.6% (1-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲55.9% (1-year basis)

ROE Trend

2.5 / 4

Avg ROE 34.2% (declining, 2yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position3.0Point

52w lower range (29%)

Current 10,770Won52-week high 16,10052-week low 8,550

1-month return1.0Point

1m -8.03% (falling)

Volume trend5.0Point

Volume increasing

Detailed Disclosure

8 totalPositive 0Neutral 8Negative 0

Neutral주식등의대량보유상황보고서(일반)2026-04-02
Neutral[첨부정정]사업보고서 (2025.12)2026-03-27
Neutral기업가치제고계획(자율공시)2026-03-24
Neutral정기주주총회결과2026-03-24
Neutral주식매수선택권부여에관한신고2026-03-24